Zacks.com featured highlights include Halozyme Therapeutics, Avnet, BILL and Venture Global
Four PEG value stocks Halozyme, Avnet, BILL and Venture Global combine discounted valuations with strong expected growth rates.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo